Search Within

Heiko Schoder

  1. "Sean Devlin"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (8)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (18)
  2. Center for Hematologic Malignancies (18)
  3. Department of Medicine (18)
  4. Epidemiology and Biostatistics (18)
  5. Hematologic Malignancies, Division of (18)
  6. Molecular Imaging and Therapy Service (18)

More Groups

People
  1. Sean Devlin (18)
  2. Miguel-Angel Perales (14)
  3. Parastoo Dahi (13)
  4. Maria Palomba (12)
  5. Michael Scordo (12)
  6. Richard Lin (12)

More People

Years
  1. 2025 (3)
  2. 2024 (3)
  3. 2023 (5)
  4. 2022 (1)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Blood (6)
  2. Bone Marrow Transplantation (2)
  3. International Journal of Radiation Oncology, Biology, Physics (2)
  4. Blood Advances (1)
  5. Blood Cancer Journal (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Elsevier Inc. (3)
  3. Nature Publishing Group (3)
  4. American Association for Cancer Research (1)
  5. Biomed Central Ltd (1)
  6. Springer (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma
    Journal Article

    Corona, M.; Ip, A.; Brown, S.; Luna, A.; Khatib, H.; Flynn, J. R.; Devlin, S. M.; Landego, I.; Cassanello, G.; Rejeski, K.; more...
    Bone Marrow Transplantation (2025)

    Fulltext@MSK | Save
  • CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
    Journal Article

    Luna, A.; Devlin, S. M.; Rejeski, K.; Flynn, J. R.; Corona, M.; Luttwak, E.; Rivas-Delgado, A.; Landego, I.; Cassanello, G.; Gomez-Llobell, M.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
    Journal Article

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
    Journal of Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT imaging biomarkers for car-T cell therapy outcomes in large-B-cell lymphoma
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M.; Luttwak, E.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT features as potent imaging biomarkers of efficacy and toxicity in large-B-cell lymphoma treated with CAR-T cell therapy
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Mauguen, A.; Devlin, S. M.; Fei, T.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; Lafontaine, D.; Michaud, L.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save